Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-02-07
1991-03-05
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514398, 514900, 514902, 424 54, A61K 31415, A61K 3143
Patent
active
049978306
ABSTRACT:
A pharmaceutical combination of Metronidazole and Amoxicillin for the treatment of periodontitis. Conventional therapeutic doses of both the Metronidazole and Amoxicillin given as a combination therapy has been unexpectedly found to effectively treat periodontitis.
REFERENCES:
patent: Re33093 (1989-10-01), Schiraldi et al.
patent: 4102998 (1978-07-01), Gutnick
patent: 4568535 (1986-02-01), Loesche
patent: 4780320 (1988-10-01), Baker
patent: 4882167 (1989-11-01), Jang
patent: 4919939 (1990-04-01), Baker
Walker C.A. 104:65767 R (1986).
Deasy C.A. 112:42395U (1990).
Chodkiewicz C.A. 111:180720B (1989).
Friedman C.A. 108:62501W (1988).
Van Ousten C.A. 106:60754R (1987).
Polson C.A. 105:601H (1986).
Britt C.A. 104:141679F (1986).
Notten C.A. 104:17591G (1986).
Baker C.A. 103:210912V (1985).
Baker C.A. 99:1550629 (1983).
Dahlen C.A. 98:27376N (1983).
Heijl C.A. 96:192982Y (1982).
Kurnman C.A. 95:91056Y (1981).
Slots C.A. 93:107964Yg (1980).
Etude Clinique Comparative entre la Rocephine (Roche) et la Doxycycline, l'Amoxycilline, l'Erythromycine et l'Association Amoxycilline+Metronidazole en Gynecologie, Georges Gaudin, Gynak. Rdsch., 1985, 25:86-95.
The Therapeutic Use of Metronidazole in Anaerobic Infection: Six Years' Experience in a London Hospital, Susannah Eykyn, Surgery, 1983, pp. 209-214.
Campylobacter Pylori-Therapy Review, A. T. R. Axon, 1989, 24 (Suppl 160), pp. 35-38.
Oral Triple Therapy (OTT) May Effectively Eradicate Campylobacter Pylori (C.p.) in Man, G. Borsch, Abstracts of Papers, Gastroenterology, vol. 94, No. 5, p. A44. (Abstract).
Factors Predicting Abnormal Hysterosalpingographic Findings in Patients Treated for Acute Pelvic Inflammatory Disease, J. Paavonen et al., Int. J. Gynaecol. Obstet., 1985, 23:171-175.
Activite in vitro ee l'Association Amoxicilline-Acide Clavulanique sur les Bacteries Anaerobies, A. Sedallian et al., Pathologie Biologie, Jun. 1988, pp. 678-681.
New Antibiotic Therapies for Human Periodontitis, T. E. Rams et al., J. Periodontal, May 1990, p. 316.
Metronidazole Plus Amoxycillin in the Treatment of Actinobacillus Actinomycetemcomitans Associated Periodontitis, Winkelhoff et al., J. Clin. Periodontal, Feb. 1989, 16, pp. 128-131.
New Antibiotics Therapies for Human Periodontitis, T. E. Rams et al., American Acedemy of Periodontology Abstract Presented at Oct. 25, 1989, Annual Meeting.
The Role of Actinobacillus Actinomycetemcomitans in Periodontal Disease, de Graffe, Van Winkelhoff, and Goene, Infection, Jul.-Aug. 1989, 17(4) pp. 269-271.
Christersson Lars A.
Genco Robert J.
Goene Ronald J.
van Winkelhoff Arie J.
Winkel Edwin G.
Dunn Michael L.
Mudd James F.
Park Ellen K.
Rose Shep K.
The Research Foundation of State University of New York
LandOfFree
Pharmaceutical composition for the treatment of periodontitis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition for the treatment of periodontitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for the treatment of periodontitis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-496918